Search
Search Constraints
You searched for: Author/Creator Zou, XiaotengLimit your search
- Zou, Xiaoteng [remove] 1
- 615.105 1
- Anlotinib -- Osimertinib -- EGFR-TKIs resistance -- AXL -- NSCLC 1
- Anlotinib(PubChem CID: 25017411) -- Osimertinib(PubChem CID: 71496458) -- SGI-7079(PubChem CID: 46870258) -- Savolitinib(PubChem CID: 68289010) 1
- Médicaments -- Recherche -- Périodiques 1
- NSCLC non-small-cell lung cancer -- LSCC lung squamous cell carcinoma -- CML chronic myeloid leukemia -- CT computed tomography -- RFA bronchoscopy-guided radiofrequency ablation -- NGS next-generation sequencing -- EGFR-TKI epidermal growth factor receptor-tyrosine kinase inhibitor -- PFS progression-free survival -- OS overall survival -- EMT epithelial-to-mesenchymal transition -- VEGFR vascular endothelial growth factor receptor -- PDGFR platelet-derived growth factor receptor -- FGFR fibroblast growth factor receptor -- KEGG Kyoto Encyclopedia of Genes and Genomes -- IC50 the half maximal inhibitory concentration -- HUVECs human umbilical vein endothelial cells -- siRNA small interfering RNA -- ChIP chromatin immunoprecipitation -- CCK-8 cell counting kit-8 1
- Pharmacologie -- Périodiques 1
- Pharmacology -- Periodicals 1
- Research -- Periodicals 1